Identification of gene signatures relevant to the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.

As shown in Figure S2, Supplemental Digital Content, http://links.lww.com/MD/O129 , the OS and PFS of the high-risk group were relatively shorter than those of the low-risk group, but this did not reach statistical significance.

also in 111,027 other papers